Big Data Investments in the Healthcare & Pharmaceutical Industry Will Account for Nearly $4.7 Billion in 2018 Alone
The "Big Data in the Healthcare & Pharmaceutical Industry: 2018 - 2030 - Opportunities, Challenges, Strategies & Forecasts" report from
Big Data originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data, to solve complex problems.
Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors. The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.
This research estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly
The report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies.
The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2018 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 37 use cases, 6 regions and 35 countries.
Key Findings
- In 2018, Big Data vendors will pocket nearly
$4.7 Billion from hardware, software and professional services revenues in the healthcare and pharmaceutical industry. These investments are further expected to grow at a CAGR of approximately 12% over the next three years, eventually accounting for more than$7 Billion by the end of 2021. - Big Data and advanced analytics are driving a paradigm shift in the healthcare and pharmaceutical industry with multiple innovations ranging from precision medicine and digital therapeutics to the adoption of accountable and value-based care models.
- Drug developers are making substantial investments in Big Data and artificial intelligence-driven drug discovery platforms to shorten the process of successfully discovering promising compounds. In addition, Big Data technologies are increasingly being utilized to streamline clinical trials, enabling biopharmaceutical companies to significantly lower costs and accelerate productive trials.
- The growing adoption of Big Data technologies has also brought about an array of benefits for hospitals and other healthcare facilities. Based on feedback from healthcare providers worldwide, these include but are not limited to cost savings in the range of 20-30%, an increase in patient access to services by more than 35%, growth in revenue by up to 30%, a reduction in emergency room visits by 10%, a drop in patient wait times by 30-60%, improvements in outcomes by as much as 20%, a 10-50% decline in mortality rates for conditions such as heart failure, and a reduction in the occurrence of hospital acquired and surgical site infections by nearly 60%.
Key Topics Covered
Chapter 1: Introduction
1.1 Executive Summary
1.2 Topics Covered
1.3 Forecast Segmentation
1.4 Key Questions Answered
1.5 Key Findings
1.6 Methodology
1.7 Target Audience
1.8 Companies & Organizations Mentioned
Chapter 2: An Overview of Big Data
2.1 What is Big Data?
2.2 Key Approaches to Big Data Processing
2.2.1 Hadoop
2.2.2 NoSQL
2.2.3 MPAD (Massively Parallel Analytic Databases)
2.2.4 In-Memory Processing
2.2.5 Stream Processing Technologies
2.2.6 Spark
2.2.7 Other Databases & Analytic Technologies
2.3 Key Characteristics of Big Data
2.3.1 Volume
2.3.2 Velocity
2.3.3 Variety
2.3.4 Value
2.4 Market Growth Drivers
2.4.1 Awareness of Benefits
2.4.2 Maturation of Big Data Platforms
2.4.3 Continued Investments by Web Giants, Governments & Enterprises
2.4.4 Growth of Data Volume, Velocity & Variety
2.4.5 Vendor Commitments & Partnerships
2.4.6 Technology Trends Lowering Entry Barriers
2.5 Market Barriers
2.5.1 Lack of
2.5.2 Uncertain Big Data Strategies
2.5.3 Organizational Resistance to Big Data Adoption
2.5.4 Technical Challenges: Scalability & Maintenance
2.5.5 Security & Privacy Concerns
Chapter 3: Big Data Analytics
3.1 What are Big Data Analytics?
3.2 The Importance of Analytics
3.3 Reactive vs. Proactive Analytics
3.4 Customer vs. Operational Analytics
3.5 Technology & Implementation Approaches
3.5.1 Grid Computing
3.5.2 In-Database Processing
3.5.3 In-Memory Analytics
3.5.4 Machine Learning & Data Mining
3.5.5 Predictive Analytics
3.5.6 NLP (Natural Language Processing)
3.5.7 Text Analytics
3.5.8 Visual Analytics
3.5.9 Graph Analytics
Chapter 4: Business Case & Applications in the Healthcare & Pharmaceutical Industry
4.1 Overview & Investment Potential
4.2 Industry Specific Market Growth Drivers
4.3 Industry Specific Market Barriers
4.4 Key Applications
4.4.1 Pharmaceutical & Medical Products
4.4.1.1 Drug Discovery, Design & Development
4.4.1.2 Medical Product Design & Development
4.4.1.3
4.4.1.4 Precision Medicine & Genomics
4.4.1.5 Manufacturing &
4.4.1.6 Post-Market Surveillance & Pharmacovigilance
4.4.1.7 Medical Product Fault Monitoring
4.4.2 Core Healthcare Operations
4.4.2.1 Clinical Decision Support
4.4.2.2 Care Coordination & Delivery Management
4.4.2.3 CER (
4.4.2.4
4.4.2.5 Data-Driven Preventive Care & Health Interventions
4.4.2.6 Surgical Practice & Complex Medical Procedures
4.4.2.7 Pathology, Medical Imaging & Other Medical Tests
4.4.2.8 Proactive & Remote Patient Monitoring
4.4.2.9 Predictive Maintenance of Medical Equipment
4.4.2.10 Pharmacy Services
4.4.3 Healthcare Support, Awareness & Disease Prevention
4.4.3.1 Self-Care & Lifestyle Support
4.4.3.2 Digital Therapeutics
4.4.3.3 Medication Adherence & Management
4.4.3.4
4.4.3.5 Population Health Management
4.4.3.6 Connected Health Communities & Medical Knowledge Dissemination
4.4.3.7 Epidemiology & Disease Surveillance
4.4.3.8 Health Policy Decision Making
4.4.3.9 Controlling Substance Abuse & Addiction
4.4.3.10
4.4.4
4.4.4.1 Health Insurance Claims Processing & Management
4.4.4.2 Fraud & Abuse Prevention
4.4.4.3 Proactive
4.4.4.5 Data-Driven Health Insurance Premiums
4.4.5 Marketing, Sales & Other Applications
4.4.5.1 Marketing & Sales
4.4.5.2 Administrative & Customer Services
4.4.5.3 Finance & Risk Management
4.4.5.4 Healthcare Data Monetization
4.4.5.5 Other Applications
Chapter 5: Healthcare & Pharmaceutical Industry Case Studies
5.1 Pharmaceutical & Medical Device Companies
5.1.1 AbbVie: Designing & Implementing Clinical Trials with Big Data
5.1.2 AstraZeneca: Analytics-Driven Drug Development with Big Data
5.1.3 Bayer: Accelerating Clinical Trials with Big Data
5.1.4 BMS (Bristol-Myers Squibb): Driving Clinical Discovery with Big Data
5.1.5 GSK (GlaxoSmithKline): Increasing Success Rates in Drug Discovery with Big Data
5.1.6 Johnson & Johnson: Intelligent Pharmaceutical Marketing with Big Data
5.1.7 Medtronic: Facilitating Predictive Care with Big Data
5.1.8 Merck & Co.: Optimizing Vaccine Manufacturing with Big Data
5.1.9 Merck KGaA: Discovering Drugs Faster with Big Data
5.2 Healthcare Providers, Insurers & Payers
5.2.1 Aetna: Predicting & Improving Health with Big Data
5.2.2 Ambulance Victoria: Improving Patient Survival Rates with Big Data
5.2.3
5.2.4 Cigna: Streamlining Health Insurance Claims with Big Data
5.2.5
5.2.6
5.2.7
5.2.8 MSQC (Michigan Surgical Quality Collaborative): Surgical Quality Improvement with Big Data
5.2.9 NCCS (National Cancer Centre Singapore): Advancing Cancer Treatment with Big Data
5.3 Other Stakeholders
5.3.1 Amino: Healthcare Transparency with Big Data
5.3.2 Atomwise: Improving Drug Discovery with Big Data
5.3.3 CosmosID: Advancing Microbial Genomics with Big Data
5.3.4 Deep Genomics: Discovering Novel Oligonucleotide Therapies with Big Data
5.3.5 Desktop Genetics: Facilitating Genome Editing with Big Data
5.3.6 Express Scripts: Improving Medication Adherence with Big Data
5.3.7
5.3.8 Genomics England: Developing the World's First Genomics Medicine Service with Big Data
5.3.9
Chapter 6: Future Roadmap & Value Chain
6.1 Future Roadmap
6.1.1 Pre-2020: Growing Investments in Real-Time & Predictive Health Analytics
6.1.2 2020 - 2025: Data-Driven Advances in Drug Discovery & Precision Medicine
6.1.3 2025 - 2030: Moving Beyond National-Level Population Health Management
6.2 The Big Data Value Chain
6.2.1 Hardware Providers
6.2.1.1 Storage & Compute Infrastructure Providers
6.2.1.2 Networking Infrastructure Providers
6.2.2 Software Providers
6.2.2.1 Hadoop & Infrastructure Software Providers
6.2.2.2 SQL & NoSQL Providers
6.2.2.3 Analytic Platform & Application Software Providers
6.2.2.4 Cloud Platform Providers
6.2.3 Professional Services Providers
6.2.4 End-to-End Solution Providers
6.2.5 Healthcare & Pharmaceutical Industry
Chapter 7: Standardization & Regulatory Initiatives
7.1 ASF (
7.1.1 Management of Hadoop
7.1.2 Big Data Projects Beyond Hadoop
7.2 CSA (
7.2.1 BDWG (
7.3 CSCC (
7.3.1
7.4 DMG (
7.4.1 PMML (Predictive Model Markup Language)
7.4.2 PFA (Portable Format for Analytics)
7.5 IEEE (
7.5.1 Big Data Initiative
7.6 INCITS (
7.6.1 Big Data Technical Committee
7.7 ISO (
7.7.1 ISO/IEC JTC 1/SC 32: Data Management and Interchange
7.7.2 ISO/IEC JTC 1/SC 38: Cloud Computing and Distributed Platforms
7.7.3 ISO/IEC JTC 1/SC 27: IT Security Techniques
7.7.4 ISO/IEC JTC 1/WG 9: Big Data
7.7.5 Collaborations with Other ISO Work Groups
7.8 ITU (
7.8.1 ITU-T Y.3600: Big Data - Cloud Computing Based Requirements and Capabilities
7.8.2 Other Deliverables Through SG (
7.8.3 Other Relevant Work
7.9
7.9.1 ODPi (Open Ecosystem of Big Data)
7.10 NIST (
7.10.1 NBD-PWG (
7.11 OASIS (
7.11.1 Technical Committees
7.12 ODaF (
7.12.1 Big Data Accessibility
7.13 ODCA (
7.13.1 Work on Big Data
7.14 OGC (
7.14.1 Big Data DWG (
7.15
7.15.1 Big Data Analytics Strategic Program
7.16 TPC (
7.16.1 TPC-BDWG (
7.17 W3C (
7.17.1
7.17.2
7.18 Other Initiatives Relevant to the Healthcare & Pharmaceutical Industry
7.18.1 HIPAA (Health Insurance Portability and Accountability Act of 1996)
7.18.2 HITECH (Health Information Technology for
7.18.3
7.18.4
7.18.5
7.18.6
7.18.7
7.18.8
7.18.9 HL7 (Health Level Seven) Specifications
Chapter 8: Market Sizing & Forecasts
8.1 Global Outlook for Big Data in the Healthcare & Pharmaceutical Industry
8.2 Hardware, Software & Professional Services Segmentation
8.3 Horizontal Submarket Segmentation
8.4 Hardware Submarkets
8.4.1 Storage and Compute Infrastructure
8.4.2 Networking Infrastructure
8.5 Software Submarkets
8.5.1 Hadoop &
8.5.2 SQL
8.5.3 NoSQL
8.5.4 Analytic Platforms & Applications
8.5.5 Cloud Platforms
8.6 Professional Services Submarket
8.6.1 Professional Services
8.7 Application Area Segmentation
8.7.1 Pharmaceutical & Medical Products
8.7.2 Core Healthcare Operations
8.7.3 Healthcare Support, Awareness & Disease Prevention
8.7.4
8.7.5 Marketing, Sales & Other Applications
8.8 Use Case Segmentation
8.9 Pharmaceutical & Medical Products
8.9.1 Drug Discovery, Design & Development
8.9.2 Medical Product Design & Development
8.9.3
8.9.4 Precision Medicine & Genomics
8.9.5 Manufacturing &
8.9.6 Post-Market Surveillance & Pharmacovigilance
8.9.7 Medical Product Fault Monitoring
8.10 Core Healthcare Operations
8.10.1 Clinical Decision Support
8.10.2 Care Coordination & Delivery Management
8.10.3 CER (
8.10.4
8.10.5 Data-Driven Preventive Care & Health Interventions
8.10.6 Surgical Practice & Complex Medical Procedures
8.10.7 Pathology, Medical Imaging & Other Medical Tests
8.10.8 Proactive & Remote Patient Monitoring
8.10.9 Predictive Maintenance of Medical Equipment
8.11 Healthcare Support, Awareness & Disease Prevention
8.11.1 Self-Care & Lifestyle Support
8.11.2 Digital Therapeutics
8.11.3 Medication Adherence & Management
8.11.4
8.11.5 Population Health Management
8.11.6 Connected Health Communities & Medical Knowledge Dissemination
8.11.7 Epidemiology & Disease Surveillance
8.11.8 Health Policy Decision Making
8.11.9 Controlling Substance Abuse & Addiction
8.12
8.12.1 Health Insurance Claims Processing & Management
8.12.2 Fraud & Abuse Prevention
8.12.3 Proactive
8.12.5 Data-Driven Health Insurance Premiums
8.13 Marketing, Sales & Other Application Use Cases
8.13.1 Marketing & Sales
8.13.2 Administrative & Customer Services
8.13.3 Finance & Risk Management
8.13.4 Healthcare Data Monetization
8.13.5 Other Use Cases
8.14 Regional Outlook
8.15
8.15.1 Country Level Segmentation
8.15.2
8.15.3
8.15.4
8.15.5
8.15.6
8.15.7
8.15.8
8.15.9
8.16
8.16.1 Country Level Segmentation
8.16.2
8.16.3
8.16.4
8.16.5 Rest of
8.17 Latin &
8.17.1 Country Level Segmentation
8.17.2
8.17.3
8.17.4
8.17.5 Rest of Latin &
8.18
8.18.1 Country Level Segmentation
8.18.2
8.18.3
8.18.4
8.18.5
8.18.6
8.18.7 Rest of the
8.19
8.19.1 Country Level Segmentation
8.19.2
8.19.3
8.20
8.20.1 Country Level Segmentation
8.20.2
8.20.3
8.20.4
8.20.5
8.20.6
8.20.7
8.20.8
8.20.9
Chapter 9: Vendor Landscape
9.1 1010data
9.2 Absolutdata
9.3 Accenture
9.4
9.5 Adaptive Insights
9.6 Adobe Systems
9.7
9.8
9.9
9.10 Alation
9.11 Algorithmia
9.12 Alluxio
9.13 ALTEN
9.14 Alteryx
9.15 AMD (Advanced Micro Devices)
9.16 Anaconda
9.17
9.18 Arcadia Data
9.19 ARM
9.20 AtScale
9.21 Attivio
9.22 Attunity
9.23 Automated Insights
9.24 AVORA
9.25 AWS (
9.26 Axiomatics
9.27
9.28
9.29
9.30 BCG (
9.31
9.32
9.33 Big Panda
9.34 BigML
9.35 Bitam
9.36 Blue Medora
9.37
9.38
9.39
9.40
9.41 Booz Allen Hamilton
9.42 Boxever
9.43 CACI International
9.44 Cambridge Semantics
9.45 Capgemini
9.46
9.47 Centrifuge Systems
9.48 CenturyLink
9.49 Chartio
9.50 Cisco Systems
9.51
9.52 ClearStory Data
9.53
9.54 Cloudera
9.55
9.56
9.57 CognitiveScale
9.58
9.59 Concurrent Technology/Vecima Networks
9.60 Confluent
9.61 Contexti
9.62
9.63 Crate.io
9.64 Cray
9.65
9.66
9.67 Datalytyx
9.68
9.69
9.70
9.71 Datawatch Corporation
9.72 DDN (DataDirect Networks)
9.73
9.74 Dell Technologies
9.75 Deloitte
9.76
9.77
9.78 Dianomic Systems
9.79
9.80 Dimensional Insight
9.81
9.82
9.83 Domo
9.84
9.85 DriveScale
9.86
9.87 Dundas Data Visualization
9.88 DXC Technology
9.89 Elastic
9.90
9.91
9.92 eQ Technologic
9.93 Ericsson
9.94 Erwin
9.95 EVO (Big Cloud Analytics)
9.96 EXASOL
9.97 EXL (ExlService Holdings)
9.98 Facebook
9.99 FICO (Fair Isaac Corporation)
9.100 Figure Eight
9.101 FogHorn Systems
9.102
9.103 Franz
9.104 Fujitsu
9.105 Fuzzy Logix
9.106
9.107
9.108 Glassbeam
9.109
9.110 Google/Alphabet
9.111
9.112 Greenwave Systems
9.113
9.114 H2O.ai
9.115 HarperDB
9.116
9.117 Hitachi Vantara
9.118 Hortonworks
9.119 HPE (Hewlett Packard Enterprise)
9.120 Huawei
9.121 HVR
9.122 HyperScience
9.123
9.124 IBM Corporation
9.125 iDashboards
9.126 IDERA
9.127 Ignite Technologies
9.128 Imanis Data
9.129 Impetus Technologies
9.130 Incorta
9.131
9.132
9.133
9.134
9.135 Informatica
9.136
9.137 Infosys
9.138 Infoworks
9.139
9.140
9.141 Intel Corporation
9.142
9.143
9.144 Jedox
9.145 Jethro
9.146
9.147 Juniper Networks
9.148 KALEAO
9.149 Keen IO
9.150 Keyrus
9.151 Kinetica
9.152 KNIME
9.153
9.154 Kyvos Insights
9.155 LeanXcale
9.156
9.157
9.158
9.159 Logi Analytics
9.160 Logical Clocks
9.161
9.162
9.163
9.164 Luminoso Technologies
9.165
9.166
9.167 MapD Technologies
9.168
9.169
9.170
9.171 Mathworks
9.172 Melissa
9.173
9.174 Metric Insights
9.175 Microsoft Corporation
9.176 MicroStrategy
9.177 Minitab
9.178 MongoDB
9.179 Mu Sigma
9.180 NEC Corporation
9.181 Neo4j
9.182 NetApp
9.183 Nimbix
9.184 Nokia
9.185 NTT Data Corporation
9.186
9.187
9.188 NVIDIA Corporation
9.189 Objectivity
9.190
9.191
9.192 Opera Solutions
9.193 Optimal Plus
9.194 Oracle Corporation
9.195
9.196 Panasonic Corporation/Arimo
9.197
9.198
9.199
9.200
9.201 Pivotal Software
9.202 Prognoz
9.203 Progress Software Corporation
9.204
9.205 Pure Storage
9.206 PwC (
9.207 Pyramid Analytics
9.208 Qlik
9.209 Qrama/Tengu
9.210 Quantum Corporation
9.211
9.212 Rackspace
9.213 Radius Intelligence
9.214 RapidMiner
9.215
9.216 Red Hat
9.217
9.218 RedPoint Global
9.219
9.220 RStudio
9.221
9.222 Ryft
9.223
9.224 Salesforce.com
9.225
9.226
9.227 SAP
9.228
9.229
9.230 Seagate Technology
9.231
9.232
9.233 Sizmek
9.234
9.235 Snowflake Computing
9.236 Software AG
9.237 Splice Machine
9.238 Splunk
9.239
9.240 Stratio
9.241 Streamlio
9.242
9.243 Striim
9.244 Sumo Logic
9.245 Supermicro (Super Micro Computer)
9.246 Syncsort
9.247 SynerScope
9.248 SYNTASA
9.249 Tableau Software
9.250
9.251 Tamr
9.252 TARGIT
9.253 TCS (Tata Consultancy Services)
9.254 Teradata Corporation
9.255 Thales/
9.256
9.257
9.258 Toshiba Corporation
9.259 Transwarp
9.260
9.261
9.262 Unravel Data
9.263 VANTIQ
9.264 VMware
9.265
9.266 WANdisco
9.267 Waterline Data
9.268 Western Digital Corporation
9.269 WhereScape
9.270 WiPro
9.271
9.272 Workday
9.273
9.274 Yellowfin BI
9.275 Yseop
9.276 Zendesk
9.277
9.278 Zucchetti
Chapter 10: Conclusion & Strategic Recommendations
10.1 Why is the Market Poised to Grow?
10.2 Geographic Outlook: Which Countries Offer the Highest Growth Potential?
10.3 Partnerships & M&A Activity: Highlighting the Importance of Big Data
10.4 Driving the Development of Digital Therapeutics
10.5 Improving Outcomes, Achieving Operational Efficiency and Reducing Costs
10.6 Assessing the Impact of Connected Health Solutions
10.7 Accelerating the Transition Towards Value-Based Care
10.8 The Emergence of Advanced AI (Artificial Intelligence) & Machine Learning Techniques
10.9 The Value of Big Data in Precision Medicine
10.10 Addressing Privacy & Security Concerns
10.11 The Role of Data Protection Legislation
10.12 Blockchain: Enabling Secure, Efficient and Interoperable Data Sharing
10.13 Recommendations
10.13.1 Big Data Hardware, Software & Professional Services Providers
10.13.2 Healthcare & Pharmaceutical Industry Stakeholders
For more information about this report visit https://www.researchandmarkets.com/research/ppf95c/big_data?w=5
Media Contact:
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Fax (outside
View original content:http://www.prnewswire.com/news-releases/big-data-investments-in-the-healthcare--pharmaceutical-industry-will-account-for-nearly-4-7-billion-in-2018-alone-300688346.html
SOURCE
If a Long-Term Disability Hasn’t Been Recognized by the Insurance Company, Abell & Capitan Law Wants to
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News